- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: FEC-T+Pertuzumab
Total 5330 results
-
Queen Mary University of LondonGilead SciencesUnknownRecurrent or Refractory B Cell Acute Lymphoblastic LeukaemiaUnited Kingdom
-
Hoffmann-La RocheCompletedHER2-Positive Early Breast CancerUnited States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
-
Shenzhen Fifth People's HospitalRecruiting
-
Gilead SciencesWithdrawnDiffuse Large B-cell Lymphoma | NHL | Non Hodgkin's Lymphoma | Aggressive NHLUnited States
-
Karie D. Runcie, MDAmgenActive, not recruiting
-
Genentech, Inc.Approved for marketing
-
AgendiaUniversity of South Florida; University of Miami; University of Oklahoma; Ohio... and other collaboratorsCompletedBreast CancerUnited States
-
Weill Medical College of Cornell UniversityGilead SciencesTerminatedFollicular LymphomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteTerminated
-
Hoffmann-La RocheCompleted
-
Shanghai Henlius BiotechCompletedHealthy Male VolunteersChina
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingBreast Cancer | Stage II Breast Cancer | HER-2 Positive Breast Cancer | Stage III Breast CancerUnited States
-
Hoffmann-La RocheActive, not recruitingInflammatory Breast Cancer | Early Breast Cancer | Locally Advanced Breast CancerCanada, Croatia, Spain, Argentina, Mexico, Korea, Republic of, Bosnia and Herzegovina, Brazil, Costa Rica, Turkey, Singapore, Bulgaria, South Africa, India, Peru, Kenya, Chile
-
MedSIRHoffmann-La RocheNot yet recruiting
-
MedSIRHoffmann-La RocheActive, not recruitingEarly Breast CancerSpain, Italy, Germany, Bulgaria, Hungary
-
University Health Network, TorontoSunnybrook Health Sciences Centre; Unity Health TorontoRecruiting
-
Zydus Lifesciences LimitedNot yet recruiting
-
Chengdu CoenBiotech Co., LtdJiangsu Province Centers for Disease Control and Prevention; Changde First... and other collaboratorsRecruiting
-
Jules Bordet InstituteHoffmann-La Roche; Breast International Group; Institut Curie; International Drug...SuspendedHER2-positive Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast Cancer | Node-negative Breast CancerKorea, Republic of, France, Israel, Belgium, Switzerland, Australia
-
Shengjing HospitalNot yet recruiting
-
Janssen Research & Development, LLCCompleted
-
Hoffmann-La RocheCompletedBreast CancerSweden, Canada, South Africa, Spain, United Kingdom, Germany, Taiwan, Switzerland, New Zealand, Italy, Bosnia and Herzegovina, Serbia, Portugal, Greece, Romania, Brazil, Korea, Republic of, Mexico, Croatia, Bahamas
-
Shanghai Jiao Tong University School of MedicineJiangsu HengRui Medicine Co., Ltd.Active, not recruitingBreast Cancer InvasiveChina
-
European Organisation for Research and Treatment...Hoffmann-La RocheCompletedElderly Metastatic Breast Cancer PopulationBelgium, Italy, Netherlands, France, Poland, United Kingdom, Portugal, Sweden
-
The Netherlands Cancer InstituteRoche Pharma AG; Borstkanker Onderzoek GroepActive, not recruitingBreast Cancer | HER2 PositiveNetherlands
-
Janssen Scientific Affairs, LLCCompleted
-
Genentech, Inc.Completed
-
Hoffmann-La RocheCompletedBreast CancerChina, Korea, Republic of, Taiwan, Thailand
-
David Garcia CincaFundacion Clinic per a la Recerca BiomédicaNot yet recruiting
-
GlaxoSmithKlineCompletedVomiting | Cardiovascular Event | Arterial Thromboembolic Event
-
Kanuni Sultan Suleyman Training and Research HospitalCompleted
-
Fudan UniversityRecruiting
-
Hoffmann-La RocheRecruitingLocally Advanced or Metastatic Breast CancerFrance, Belgium, United States, Korea, Republic of, Taiwan, China, Italy, Argentina, Jordan, Mexico, Brazil, Germany, Portugal, Thailand, Turkey, United Kingdom, Kenya, Spain, Hungary, Colombia, India, Oman, Poland, Uganda, United Arab...
-
BiocadRecruitingBreast CancerRussian Federation
-
Ontario Clinical Oncology Group (OCOG)Terminated
-
Royal Marsden NHS Foundation TrustCompletedMelanoma and SarcomaUnited Kingdom
-
Hoffmann-La RocheActive, not recruiting
-
BiocadActive, not recruiting
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Institutes of Health (NIH)RecruitingHER2-positive Metastatic Breast Cancer | HER-2 Protein Overexpression | HER-2 Positive Malignant Carcinoma of BreastUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedHER2-positive Carcinoma | HER2-positive Primary MalignancyUnited States
-
Genentech, Inc.Completed
-
Dan Blazer III, M.D.CompletedStage IV Peritoneal Surface Dissemination From Gastrointestinal or Recurrent, Platinum-resistant Ovarian Cancer That Cannot be Completely ResectedUnited States
-
University of ZurichCompletedMerkel Cell Carcinoma | Basal Cell Carcinoma | Squamous Cell Carcinoma | Non-melanoma Skin Cancer | Cutaneous LymphomaSwitzerland
-
AmgenCompletedUnresectable Stage IIIB-IV Malignant MelanomaJapan
-
The University of Texas Health Science Center,...Baylor College of Medicine; Duke University; Centers for Disease Control and... and other collaboratorsCompleted
-
Cancer Institute and Hospital, Chinese Academy...Completed
-
Fudan UniversityCompleted
-
Hospices Civils de LyonNot yet recruiting
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Roche Pharma AGCompletedEsophageal CarcinomaNetherlands